pathology microbiology and immunology Archive
-
August 31, 2023
Cindy Lowe of Translational Pathology Shared Resource wins award from National Society of Histotechnology
Cindy Lowe, research assistant in the Translational Pathology Shared Resource at VUMC, has won the National Society of Histotechnology’s Jules Elias Excellence in Immunohistochemistry & Molecular Techniques Award. -
July 14, 2023
Hogan named to American Society for Clinical Pathology ‘40 Under Forty’ list
Vanderbilt's Melissa Straub Hogan, MD, has been named to the 2023 American Society for Clinical Pathology 40 Under Forty list. -
June 28, 2023
Vanderbilt mourns loss of former ‘godfather of grants’ John Hoover Hash
John Hoover Hash, PhD, who as associate dean for Biomedical Sciences and director of Sponsored Research at Vanderbilt University Medical Center oversaw the computerization of VUMC’s grant recording system in the 1980s, died in Nashville on June 20. He was 94. -
June 27, 2023
Rare disorder sheds light on dysbindin function
A case study of a rare disorder uncovers roles for the protein dysbindin in the adaptive immune response and suggests that mutations may underlie some cases of very early onset inflammatory bowel disease. -
April 20, 2023
Study details RNA editing in virus-infected cancer cells
Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection. -
March 30, 2023
NIH grant launches C. diff vaccine research initiative
Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV. -
March 23, 2023
Mathers Foundation award supports study of bacterial physiology
Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases.